VanEck Pharmaceutical ETF (PPH) Dividend History

Dividend Yield: 2.18%

Dividend Frequency: Quarterly

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
July 07, 2025	$0.61	07/01/2025	07/01/2025
April 04, 2025	$0.52	04/01/2025	04/01/2025
December 30, 2024	$0.41	12/27/2024	12/27/2024
October 04, 2024	$0.41	10/01/2024	10/01/2024
July 05, 2024	$0.36	07/01/2024	07/01/2024
April 05, 2024	$0.53	04/01/2024	04/02/2024
December 29, 2023	$0.31	12/27/2023	12/28/2023
October 06, 2023	$0.34	10/02/2023	10/03/2023
July 07, 2023	$0.39	07/03/2023	07/05/2023
April 10, 2023	$0.66	04/03/2023	04/04/2023
December 30, 2022	$0.24	12/28/2022	12/29/2022
October 07, 2022	$0.27	10/03/2022	10/04/2022
July 08, 2022	$0.25	07/01/2022	07/05/2022
April 07, 2022	$0.44	04/01/2022	04/04/2022
December 31, 2021	$0.27	12/29/2021	12/30/2021
October 07, 2021	$0.35	10/01/2021	10/04/2021
July 08, 2021	$0.29	07/01/2021	07/02/2021
April 08, 2021	$0.35	04/01/2021	04/05/2021
January 05, 2021	$0.27	12/29/2020	12/30/2020
October 07, 2020	$0.25	10/01/2020	10/02/2020
July 08, 2020	$0.25	07/01/2020	07/02/2020
April 07, 2020	$0.34	04/01/2020	04/02/2020
January 06, 2020	$0.17	12/30/2019	12/31/2019
October 07, 2019	$0.29	10/01/2019	10/02/2019
July 08, 2019	$0.28	07/01/2019	07/02/2019
April 05, 2019	$0.39	04/01/2019	04/02/2019
January 03, 2019	$0.20	12/27/2018	12/28/2018
October 05, 2018	$0.23	10/01/2018	10/02/2018
July 09, 2018	$0.25	07/02/2018	07/03/2018
April 06, 2018	$0.39	04/02/2018	04/03/2018
January 03, 2018	$0.15	12/27/2017	12/28/2017
October 06, 2017	$0.22	10/02/2017	10/03/2017
July 10, 2017	$0.30	07/03/2017	07/06/2017
April 07, 2017	$0.47	04/03/2017	04/05/2017
January 04, 2017	$0.14	12/28/2016	12/30/2016
October 07, 2016	$0.21	10/03/2016	10/05/2016
July 08, 2016	$0.29	07/01/2016	07/06/2016
April 07, 2016	$0.63	04/01/2016	04/05/2016
January 05, 2016	$0.20	12/29/2015	12/31/2015
October 07, 2015	$0.28	10/01/2015	10/05/2015
July 08, 2015	$0.28	07/01/2015	07/06/2015
April 08, 2015	$0.50	04/01/2015	04/06/2015
January 05, 2015	$0.24	12/29/2014	12/31/2014
October 07, 2014	$0.20	10/01/2014	10/03/2014
July 08, 2014	$0.25	07/01/2014	07/03/2014
April 07, 2014	$0.40	04/01/2014	04/03/2014
January 03, 2014	$0.17	12/27/2013	12/31/2013
October 07, 2013	$0.21	10/01/2013	10/03/2013
July 08, 2013	$0.27	07/01/2013	07/03/2013
April 05, 2013	$0.39	04/01/2013	04/03/2013
December 31, 2012	$1.35	12/24/2012	12/27/2012
January 07, 2009	$0.01	12/19/2008	12/23/2008
December 12, 2008	$0.05	11/12/2008	11/14/2008
December 11, 2008	$0.12	11/21/2008	11/25/2008
December 04, 2008	$0.19	11/05/2008	11/07/2008
December 03, 2008	$0.00	11/06/2008	11/10/2008
December 03, 2008	$0.04	11/10/2008	11/13/2008

Dividends Summary

VanEck Pharmaceutical ETF has issued 57 dividend payments over the past 17 years
The most recent dividend was paid 16 days ago, on July 7, 2025
The first recorded dividend was paid on December 3, 2008
The highest dividend payout was $1.35 per share
The average dividend over this 17 year span is $0.31 per share
VanEck Pharmaceutical ETF has increased its dividend payments by 1585.83% since 2008

Company News

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

Smart Beta ETF report for PJP

Zacks Investment Research

Featured Companies: ABBV IHE LLY MRK PJP
Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage

Novo Nordisk A/S (NYSE:NVO)’s Wegovy garnered the Food and Drug Administration’s approval for expanded use Friday, marking what the drugmaker said is a pivotal turn in the treatment landscape for individuals grappling with the dual challenges of obesity and established cardiovascular disease. This approval underscores a new era in preventive health strategies, targeting a significant reduction in major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attacks (myocardial infarction) and nonfatal strokes. Leap Forward In Cardiovascular, Weight Management Therapy The FDA’s green light is anchored in the ...Full story available on Benzinga.com

Benzinga
Technology Leader Pushpay Announces Executive Leadership Hire, Welcomes Burt Y. Chao as Chief Financial Officer

Chao will lead Pushpay’s finance and accounting teams, optimizing financial performance for the now privately held SaaS company Chao will lead Pushpay’s finance and accounting teams, optimizing financial performance for the now privately held SaaS company

GlobeNewswire Inc.
Schumer provides 'rock-solid evidence' that Democrats will push forward with partisan tax and spending bill, analyst says

Democrats have long hoped to coalesce around a plan to roll back some of Donald Trump's tax cuts for wealthy individuals and corporations to pay for new spending on healthcare and the fight against climate change, and it appears that plan is finally taking shape.

MarketWatch

Featured Companies: SOXX

Page data last updated 07/23/2025 21:52:25 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included